# Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders Trial

> **NCT06488105** · PHASE2 · RECRUITING · sponsor: **Wake Forest University Health Sciences** · enrollment: 130 (estimated)

## Conditions studied

- Lipid Disorder
- Hypercholesterolemia
- Cardiovascular Diseases
- Atherosclerosis

## Interventions

- **DRUG:** Statin (rosuvastatin 10 or 40 mg daily, depending on risk)
- **BEHAVIORAL:** Healthy Lifestyle Counseling
- **OTHER:** Outpatient Followup

## Key facts

- **NCT ID:** NCT06488105
- **Lead sponsor:** Wake Forest University Health Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-08-05
- **Primary completion:** 2027-11-30
- **Final completion:** 2029-03-31
- **Target enrollment:** 130 (ESTIMATED)
- **Last updated:** 2026-02-27

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06488105

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06488105, "Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders Trial". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06488105. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*